{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:39:01Z","timestamp":1792093141122,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jgar.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:55:00Z","timestamp":1557834900000},"page":"255-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Efficacy of newly isolated and highly potent bacteriophages in a mouse model of extensively drug-resistant Acinetobacter baumannii bacteraemia"],"prefix":"10.1016","volume":"19","author":[{"given":"Lika","family":"Leshkasheli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mzia","family":"Kutateladze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Balarjishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darejan","family":"Bolkvadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Save","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Oechslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yok-Ai","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Resch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2019.05.005_bib0005","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/jcm.35.11.2819-2825.1997","article-title":"Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods","volume":"35","author":"Seifert","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2019.05.005_bib0010","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/iub.534","article-title":"Acinetobacter infection\u2014an emerging threat to human health","volume":"63","author":"Visca","year":"2011","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jgar.2019.05.005_bib0015","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2019.05.005_bib0020","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1086\/655995","article-title":"Progress and challenges in implementing the research on ESKAPE pathogens","volume":"31 Suppl 1","author":"Rice","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2019.05.005_bib0025","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1097\/CCM.0b013e3181a037ac","article-title":"Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units","volume":"37","author":"Koulenti","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jgar.2019.05.005_bib0030","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1592\/phco.26.8.1099","article-title":"Tigecycline: first of a new class of antimicrobial agents","volume":"26","author":"Rose","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jgar.2019.05.005_bib0035","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2146\/ajhp050487","article-title":"Tigecycline: a new glycylcycline antimicrobial agent","volume":"63","author":"Kasbekar","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jgar.2019.05.005_bib0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dkl441","article-title":"Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report","volume":"59","author":"Peleg","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.05.005_bib0045","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1128\/AAC.01198-06","article-title":"Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii","volume":"51","author":"Peleg","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.05.005_bib0050","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3349\/ymj.2012.53.5.974","article-title":"Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection","volume":"53","author":"Shin","year":"2012","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jgar.2019.05.005_bib0055","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/jac\/dkr082","article-title":"Emergence of NDM-1-producing Acinetobacter baumannii in China","volume":"66","author":"Chen","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.05.005_bib0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.6026\/97320630008445","article-title":"Studies on New Delhi metallo-beta-lactamse-1 producing Acinetobacter baumannii isolated from donor swab in a tertiary eye care centre, India and structural analysis of its antibiotic binding interactions","volume":"8","author":"Sowmiya","year":"2012","journal-title":"Bioinformation"},{"key":"10.1016\/j.jgar.2019.05.005_bib0065","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/529198","article-title":"Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options","volume":"46","author":"Maragakis","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.05.005_bib0070","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cid\/cit152","article-title":"10 x\u2019 20 progress\u2014development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America","volume":"56","author":"Boucher","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.05.005_bib0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.tim.2012.12.002","article-title":"Emerging therapies for multidrug resistant Acinetobacter baumannii","volume":"21","author":"Garcia-Quintanilla","year":"2013","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jgar.2019.05.005_bib0080","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1128\/AAC.49.8.3198-3202.2005","article-title":"Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii","volume":"49","author":"Heritier","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.05.005_bib0085","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 8.1","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2018"},{"key":"10.1016\/j.jgar.2019.05.005_bib0090","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.jgar.2019.05.005_bib0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J Comput Biol"},{"key":"10.1016\/j.jgar.2019.05.005_bib0100","unstructured":"ORF Finder 2015. http:\/\/www.ncbi.nlm.nih.gov\/gorf\/orfig.cgi. [Accessed 8 May]"},{"key":"10.1016\/j.jgar.2019.05.005_bib0105","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","article-title":"Prokka: rapid prokaryotic genome annotation","volume":"30","author":"Seemann","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jgar.2019.05.005_bib0110","first-page":"35","article-title":"How to calculate sample size in animal studies?","volume":"1","author":"Shah","year":"2011","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"10.1016\/j.jgar.2019.05.005_bib0115","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/clinids\/22.6.1026","article-title":"Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features","volume":"22","author":"Cisneros","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.05.005_bib0120","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1159\/000486117","article-title":"Phage Abp1 rescues human cells and mice from infection by pan-drug resistant Acinetobacter baumannii","volume":"44","author":"Yin","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jgar.2019.05.005_bib0125","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3389\/fmicb.2016.01590","article-title":"Characterization and testing the efficiency of Acinetobacter baumannii phage vB-GEC_Ab-M-G7 as an antibacterial agent","volume":"7","author":"Kusradze","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2019.05.005_bib0130","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/AAC.02877-15","article-title":"Personalized therapeutic cocktail of wild environmental phages rescues mice from Acinetobacter baumannii wound infections","volume":"60","author":"Regeimbal","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.05.005_bib0135","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1128\/AEM.00526-16","article-title":"In vivo application of bacteriophage as a potential therapeutic agent to control OXA-66-like carbapenemase-producing Acinetobacter baumannii strains belonging to sequence type 357","volume":"82","author":"Jeon","year":"2016","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jgar.2019.05.005_bib0140","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2217\/fmb.16.11","article-title":"Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia","volume":"11","author":"Wang","year":"2016","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jgar.2019.05.005_bib0145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/mdr.2014.0120","article-title":"Ability of bacteriophage in resolving wound infection caused by multidrug-resistant Acinetobacter baumannii in uncontrolled diabetic rats","volume":"21","author":"Shivaswamy","year":"2015","journal-title":"Microb Drug Res"},{"key":"10.1016\/j.jgar.2019.05.005_bib0150","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.05.005_bib0155","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1128\/AAC.04641-14","article-title":"Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model","volume":"59","author":"Lood","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.05.005_bib0160","doi-asserted-by":"crossref","first-page":"11477","DOI":"10.1038\/s41598-017-11832-7","article-title":"Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2","volume":"7","author":"Peng","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2019.05.005_bib0165","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s11095-014-1617-7","article-title":"Quality and safety requirements for sustainable phage therapy products","volume":"32","author":"Pirnay","year":"2015","journal-title":"Pharm Res"},{"key":"10.1016\/j.jgar.2019.05.005_bib0170","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s00705-014-2055-x","article-title":"Efficiency of bacteriophage therapy against Cronobacter sakazakii in Galleria mellonella (greater wax moth) larvae","volume":"159","author":"Abbasifar","year":"2014","journal-title":"Arch Virol"},{"key":"10.1016\/j.jgar.2019.05.005_bib0175","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijantimicag.2015.04.005","article-title":"Assessing phage therapy against Pseudomonas aeruginosa using a Galleria mellonella infection model","volume":"46","author":"Beeton","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2019.05.005_bib0180","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/21505594.2015.1135289","article-title":"Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing","volume":"7","author":"Tsai","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.jgar.2019.05.005_bib0185","first-page":"703","article-title":"Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence","volume":"215","author":"Oechslin","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2019.05.005_bib0190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fmicb.2015.00343","article-title":"Virulence reduction in bacteriophage resistant bacteria","volume":"6","author":"Leon","year":"2015","journal-title":"Front Microbiol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519301158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519301158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:54:49Z","timestamp":1761990889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519301158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":38,"alternative-id":["S2213716519301158"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.05.005","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of newly isolated and highly potent bacteriophages in a mouse model of extensively drug-resistant Acinetobacter baumannii bacteraemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}